• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    5.42 Down 0.24(4.16%) 4:00PM EDT
    |After Hours : 5.42 0.00 (0.00%) 5:10PM EDT
    Add to Portfolio
    Prev Close:5.65
    Open:5.50
    Bid:5.41 x 1100
    Ask:5.50 x 10000
    1y Target Est:7.00
    Beta:0.81348
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:5.40 - 5.64
    52wk Range:4.58 - 10.26
    Volume:3,148,885
    Avg Vol (3m):2,538,570
    Market Cap:889.02M
    P/E (ttm):2.87
    EPS (ttm):1.89
    Div & Yield:0.60 (10.95%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 4.16%889.02M
    AMGNDown 2.85%111.81B
    SGENDown 2.36%4.93B
    XOMADown 6.10%92.52M

    Key Statistics

    Forward P/E (1 yr):7.42
    P/S (ttm):1.85
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.17
    Quarterly EPS Est (Sep-15) :0.61
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback